| scholarly article | Q13442814 |
| P50 | author | Jacqueline French | Q37836756 |
| Ildefonso Rodriguez-Leyva | Q40285524 | ||
| P2093 | author name string | J K Johnson | |
| P Baroldi | |||
| S T Brittain | |||
| PROSPER Investigators Study Group | |||
| P2860 | cites work | Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures | Q24239996 |
| Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304 | Q24621743 | ||
| Dosing frequency and medication adherence in chronic disease | Q26830504 | ||
| Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy | Q28273764 | ||
| Change in oxcarbazepine (Trileptal) formulation is associated with more side effects and higher blood concentrations | Q28363039 | ||
| How often is medication taken as prescribed? A novel assessment technique | Q34525872 | ||
| Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis | Q36891527 | ||
| Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population | Q37010482 | ||
| Extended-release formulations of antiepileptic drugs: rationale and comparative value | Q37423598 | ||
| Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis | Q37832531 | ||
| Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study | Q42659733 | ||
| Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy | Q46974457 | ||
| An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly | Q47779602 | ||
| Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs | Q50158883 | ||
| Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine. | Q51377425 | ||
| Clinical features associated with placebo response in refractory focal epilepsy. | Q52884583 | ||
| Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. | Q53523424 | ||
| A sharper Bonferroni procedure for multiple tests of significance | Q56622251 | ||
| Dose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical Trial | Q71813622 | ||
| Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group | Q73068424 | ||
| Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy | Q73291422 | ||
| Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy | Q83152998 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 143-153 | |
| P577 | publication date | 2013-12-21 | |
| P1433 | published in | Acta Neurologica Scandinavica | Q4676732 |
| P1476 | title | Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial | |
| P478 | volume | 129 |
| Q88190481 | A new enantioselective CE method for determination of oxcarbazepine and licarbazepine after fungal biotransformation |
| Q47926989 | A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures |
| Q49882750 | Antiepileptic drugs in development pipeline: A recent update |
| Q42113049 | Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis |
| Q38942227 | Epilepsy treatment in adults and adolescents: Expert opinion, 2016. |
| Q47235722 | Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence. |
| Q36284727 | Evaluate the Efficacy and Safety of Anti-Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta-Analysis |
| Q64993345 | From clinical trials of antiepileptic drugs to treatment. |
| Q38942572 | Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis. |
| Q38637882 | Is a separate monotherapy indication warranted for antiepileptic drugs? |
| Q37295962 | Long-term efficacy and safety of adjunctive extended-release oxcarbazepine (Oxtellar XR® ) in adults with partial-onset seizures |
| Q38586750 | Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects |
| Q53277220 | Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsy. |
| Q53057610 | Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study. |
| Q90026951 | Oxcarbazepine add-on for drug-resistant focal epilepsy |
| Q34518509 | Practice Update: Review of Anticonvulsant Therapy |
| Q91739549 | Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of th |
| Q91307166 | Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial |
| Q38221187 | Sodium channel antagonists for the treatment of migraine |
| Q38249142 | USL255 extended-release topiramate for the treatment of epilepsy |
Search more.